Comparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery Embolization

Recruiting Observational Study
Resistant Hypertension Secondary Hypertension Secondary Hypertension to Endocrine Disorders Primary Aldosteronism
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
196 (estimated)
Sponsor
First Affiliated Hospital of Chengdu Medical College · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
To explore the relationship between perioperative blood pressure and catecholamine concentrations in adrenal venous blood and peripheral venous blood in hypertensive patients with primary aldosteronism (PA) who underwent percutaneous selective adrenal artery embolization (SAAE). In order to elucidate the related phenomena and possible mechanisms of blood pressure fluctuations caused by SAAE treatm…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age ≥18 years with no gender restrictions. 2. Adherence to the "Primary Aldosteronism" Diagnosis and Treatment Guidelines, confirmed diagnosis of primary aldosteronism following rigorous drug washout, and identification as either aldosteronoma or idiopathic aldosteronism via …
Contacts

Peijian Wang, PhD

028-83016145

wpjmed@aliyun.com

CONTACT

Sen Liu, MD

028-83016150

463387160@qq.com

CONTACT